Home » Topics » Regulatory » Patents

Patents
RSS

Sumitomo synthesizes new series of ECE inhibitors

Dec. 17, 1997

Dainippon discloses new H+/K+-ATPase inhibitors

Dec. 17, 1997

Neovascularization inhibitors from Tsumura Juntendo

Dec. 17, 1997

Farnesyltransferase inhibitors claimed by Banyu

Dec. 17, 1997

Selective COX-2 inhibitors under development at Merck Frosst

Dec. 16, 1997

ViroPharma develops agents for HCV infection

Dec. 16, 1997

5-HT receptor (ant)agonists from Pfizer

Dec. 16, 1997

Natural anti-HIV agent disclosed by Hoechst

Dec. 16, 1997

Searle describes selective alphav/beta3 integrin antagonists

Dec. 16, 1997

Agents for HCV infection from ViroPharma

Dec. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...